Use of an Acute Seroconversion Panel To Evaluate a Third-Generation Enzyme-Linked Immunoassay for Detection of Human Immunodeficiency Virus-Specific Antibodies Relative to Multiple Other Assays

Abstract
A human immunodeficiency virus type 1 (HIV-1)/HIV-2 antibody screening assay, the Genetic Systems HIV-1/HIV-2 PLUS O EIA, was compared to several established screening or confirmatory tests using an acute HIV seroconversion panel. The HIV-1/HIV-2 PLUS O EIA showed an improved sensitivity over all tested antibody screening methods, and detected antibody in 7 of 19 specimens found to be negative by a first-generation EIA but positive for the presence of HIV RNA.